IPG Photonics (IPGP) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
18 Jan, 2026Executive summary
Q3 2024 revenue declined 23% year-over-year to $233 million, reaching the high end of guidance despite muted demand in industrial and e-mobility markets.
Net loss was $233.6 million (GAAP EPS: -$5.33), driven by a $198 million loss on Russian divestiture and $27 million in asset impairments; adjusted EPS was $0.29.
Completed the sale of Russian operations and began winding down Belarusian operations due to sanctions, shifting manufacturing to other regions.
Announced acquisition of CleanLaser to expand presence in industrial cleaning, supporting long-term growth.
Maintained strong cash position with over $1 billion and no debt, supporting agility and future investments.
Financial highlights
Q3 2024 revenue: $233.1 million, down from $301.4 million in Q3 2023 and $257.6 million in Q2 2024.
GAAP gross margin was 23.2%, down from 44.1% a year ago, mainly due to inventory provisions and underabsorption; adjusted gross margin was 36%.
GAAP operating loss was $253 million, including $198 million loss on Russian asset sale and $27 million in asset impairments.
Adjusted EPS was $0.29, at the top end of guidance.
Cash from operations was $66 million; $74 million spent on share repurchases in Q3.
Outlook and guidance
Q4 2024 revenue expected between $210 million and $240 million, with gross margin of 35%–38% and EPS guidance of $0.05–$0.35 per diluted share.
CleanLaser acquisition expected to add ~$30 million revenue in its first year, neutral to GAAP operating income.
Management expects continued investment in capacity outside Russia and Belarus, with $100 million in capital expenditures planned for 2024.
No visibility into improved demand; cautious outlook continues.
Latest events from IPG Photonics
- Growth driven by innovation, new markets, and strong financials positions the business for expansion.IPGP
47th Annual Raymond James Institutional Investor Conference2 Mar 2026 - Q4 revenue up 17% year-over-year, with strong gains in medical and advanced applications.IPGP
Q4 202512 Feb 2026 - Q2 revenue fell 24% YoY to $257.6M–$258M; cash flow strong despite weak demand.IPGP
Q2 20242 Feb 2026 - Transitioning from legacy cutting to high-growth welding, EV, and medical markets, with robust innovation.IPGP
The Stifel 2024 Cross Sector Insight Conference31 Jan 2026 - Industrial laser innovation, market diversification, and stable financials drive future growth.IPGP
Bank of America Global Industrials Conference 202526 Dec 2025 - Poised for growth with strong cash flow, margin recovery, and expanding opportunities in new markets.IPGP
Raymond James 46th Annual Institutional Investors Conference23 Dec 2025 - Q4 revenue dropped 22% YoY, but gross margin and cash flow improved amid weak demand.IPGP
Q4 202417 Dec 2025 - Shareholders to vote on directors, pay, new incentive plan, and auditor amid strategic shifts.IPGP
Proxy Filing1 Dec 2025 - Director elections, executive pay, incentive plan, and auditor ratification up for vote May 20, 2025.IPGP
Proxy Filing1 Dec 2025